LBF20207PG41: Difference between revisions

No edit summary
No edit summary
Line 7: Line 7:
|LipidMaps=LMFA03010102
|LipidMaps=LMFA03010102
|SysName=9alpha,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid
|SysName=9alpha,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid
|Common Name=&&15 (R) -Prostaglandin D_2&&9alpha,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid&&
|Common Name=&&15 (R) -Prostaglandin D_2&&
|Source=
|Source=
|Chemical Synthesis=
|Chemical Synthesis=

Revision as of 21:00, 14 April 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



15 (R) -Prostaglandin D2
LBF20207PG41.png
Structural Information
9α,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid
  • 15 (R) -Prostaglandin D2
Formula C20H32O5
Exact Mass 352.224974134
Average Mass 352.46508
SMILES C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC
Physicochemical Information
15(R)-PGD2 is reported to have potent agonistic effect to the DP2 receptor 5 time higher than PGD2. Giles_H et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207PG41 See above. Giles_H et al. 1989